AVPT.NASDAQAvepoint, INC

8-K: AvePoint's Warrant Purchase Offer Expires with Low Tender Rate, Amendment Fails

Sentiment:

Warrant Offer Results


AvePoint's offer to purchase its outstanding warrants expired with only 9.1% tendered, and a related amendment to allow redemption of remaining warrants failed to pass.

Worse than expectedThe tender offer had a low participation rate of only 9.1%, indicating that the offer was not attractive to the majority of warrant holders.The failure of the warrant amendment means the company cannot redeem the remaining warrants at the desired lower price, which is worse than the company's apparent intention.

Summary

  • AvePoint offered to purchase all of its outstanding public warrants for $2.50 each in cash.
  • The offer expired on September 24, 2024, with only 1,596,314 warrants, representing approximately 9.1% of the total outstanding, being validly tendered.
  • AvePoint accepted all validly tendered warrants and expects to pay approximately $4.0 million in total.
  • A consent solicitation to amend the warrant agreement to allow AvePoint to redeem remaining warrants for $2.00 each failed, as it did not reach the required 50.1% approval threshold.
  • The warrant amendment was intended to allow AvePoint to redeem the remaining warrants at a lower price than the offer.

Sentiment

Score: 4

Explanation: The sentiment is somewhat negative due to the low tender rate and the failure of the warrant amendment, indicating a lack of investor enthusiasm for the offer and a potential challenge for the company in managing its capital structure.

Positives

  • AvePoint successfully purchased the tendered warrants, reducing the number of outstanding warrants.
  • The company has a clear path forward regarding the warrants, even though the amendment failed.

Negatives

  • The low tender rate of 9.1% suggests that most warrant holders did not find the offer attractive.
  • The failure of the warrant amendment means AvePoint cannot redeem the remaining warrants at the desired $2.00 price.
  • The company will need to consider alternative strategies to manage the remaining warrants.

Risks

  • The remaining warrants could potentially dilute the company's stock if exercised.
  • The company may face challenges in managing the remaining warrants given the failed amendment.
  • The low tender rate may indicate a lack of confidence from warrant holders in the company's future prospects.

Future Outlook

The company expects to settle the purchase of the tendered warrants promptly. AvePoint does not intend to update or revise forward-looking statements after the date of the release, except as required by law.

Management Comments

  • AvePoint announced the expiration and results of its offer to purchase warrants.
  • AvePoint stated that they have accepted all validly tendered warrants for purchase and expect to settle such purchase promptly.

Industry Context

The use of warrants is a common practice in special purpose acquisition companies (SPACs), and this announcement reflects AvePoint's efforts to manage its capital structure following its merger with Apex Technology Acquisition Corporation. The low tender rate and failed amendment suggest that warrant holders may have different expectations about the company's future performance.

Comparison to Industry Standards

  • The tender offer for warrants is a common mechanism for companies that have gone public via SPACs to manage their capital structure.
  • The low tender rate of 9.1% is relatively low compared to some other warrant tender offers, which can sometimes see tender rates of 50% or more.
  • The failure of the warrant amendment is not uncommon, as it requires a significant majority of warrant holders to agree, and they may have different investment objectives.

Stakeholder Impact

  • Shareholders may be concerned about the potential dilution from the remaining warrants.
  • Warrant holders who did not tender their warrants will retain their warrants, but the value may be affected by the failed amendment.
  • The company's management will need to address the remaining warrants and their potential impact on the company's capital structure.

Next Steps

  • AvePoint will settle the purchase of the tendered warrants promptly.
  • AvePoint will file a final amendment to its Schedule TO to disclose the final results of the Offer.
  • The company will need to consider alternative strategies to manage the remaining warrants.

Key Dates

DateDescription
September 16, 2019Date of the Warrant Agreement between Apex Technology Acquisition Corporation and Continental Stock Transfer & Trust Company.
September 19, 2019Date of the initial public offering of Apex Technology Acquisition Corporation, which included the warrants.
August 27, 2024Initial date of the Offer to Purchase and Schedule TO.
September 24, 2024Expiration date of the warrant purchase offer.
September 25, 2024Date of the 8-K filing.
September 26, 2024Date of the press release announcing the results of the offer and consent solicitation.

Keywords

warrants, tender offer, consent solicitation, redemption, AvePoint, AVPT, AVPTW

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.